4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
8.83
-0.01 (-0.11%)
Jun 12, 2026, 4:00 PM EDT - Market closed
4D Molecular Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $36 | Buy | Reiterates | $36 | +307.70% | May 11, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $26 | Buy | Reiterates | $26 | +194.45% | May 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $35 | Buy | Maintains | $35 | +296.38% | May 8, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $38 → $33 | Buy | Maintains | $38 → $33 | +273.73% | May 8, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $29 | Buy | Reiterates | $29 | +228.43% | May 8, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $45 → $23 | Buy | Maintains | $45 → $23 | +160.48% | Apr 13, 2026 |
| Jefferies | Jefferies | Buy Initiates $40 → $21 | Buy | Initiates | $40 → $21 | +137.83% | Mar 30, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Mar 19, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.